These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 16288376

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge.
    Heineman TC, Pesnicak L, Ali MA, Krogmann T, Krudwig N, Cohen JI.
    Vaccine; 2004 Jun 30; 22(20):2558-65. PubMed ID: 15193381
    [Abstract] [Full Text] [Related]

  • 45. A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.
    Halford WP, Püschel R, Gershburg E, Wilber A, Gershburg S, Rakowski B.
    PLoS One; 2011 Mar 11; 6(3):e17748. PubMed ID: 21412438
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA, Srivastava R, Chentoufi AA, Geertsema R, Thai NT, Dasgupta G, Osorio N, Kalantari M, Nesburn AB, Wechsler SL, BenMohamed L.
    J Virol; 2015 Jul 11; 89(13):6619-32. PubMed ID: 25878105
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes.
    Veselenak RL, Shlapobersky M, Pyles RB, Wei Q, Sullivan SM, Bourne N.
    Vaccine; 2012 Nov 19; 30(49):7046-51. PubMed ID: 23041125
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection.
    Bernstein DI, Tepe ER, Mester JC, Arnold RL, Stanberry LR, Higgins T.
    Vaccine; 1999 Apr 09; 17(15-16):1964-9. PubMed ID: 10217595
    [Abstract] [Full Text] [Related]

  • 55. Vaccination strategies to prevent genital herpes and neonatal herpes simplex virus (HSV) disease.
    Jones CA, Cunningham AL.
    Herpes; 2004 Apr 09; 11(1):12-7. PubMed ID: 15115632
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.
    Boukhvalova M, McKay J, Mbaye A, Sanford-Crane H, Blanco JC, Huber A, Herold BC.
    J Virol; 2015 Oct 09; 89(19):9825-40. PubMed ID: 26178984
    [Abstract] [Full Text] [Related]

  • 58. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
    Gallichan WS, Rosenthal KL.
    Virology; 1996 Oct 15; 224(2):487-97. PubMed ID: 8874509
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The mucosal adjuvant effect of alpha-galactosylceramide for induction of protective immunity to sexually transmitted viral infection.
    Lindqvist M, Persson J, Thörn K, Harandi AM.
    J Immunol; 2009 May 15; 182(10):6435-43. PubMed ID: 19414797
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.